⌘K

Login Start Free

Home/Filings/4/A/0001209191-17-013934

4/A//SEC Filing

Adamas Pharmaceuticals Inc 4/A

Accession 0001209191-17-013934

CIK 0001328143operating

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:35 PM ET

Size

8.4 KB

Accession

0001209191-17-013934

Insider Transaction Report

Form 4/AAmended

Period: 2016-06-15

Adamas Pharmaceuticals IncADMS

DirectorChief Executive Officer10% Owner

Transactions

Exercise/Conversion
Common Stock
2016-06-15$1.88/sh+204,900$384,188→ 263,658 total

Documents

2 files

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001328143

Filing Metadata

Form type: 4/A
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 5:35 PM ET
Size: 8.4 KB

View on SEC.gov